PACIFIC SMILES GROUP LIMITED (PSQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

PSQ - PACIFIC SMILES GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.59
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.03

01 Dec
2023

-0.060

OPEN

$1.03

-5.50%

HIGH

$1.05

168,321

LOW

$1.02

TARGET
$2.10 103.9% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . ALC . BMT . CAJ . DOC . EBO . HLA . HLS . M7T . MDR . MPL . MVF . NHF . RHC . SHL .
FNARENA'S MARKET CONSENSUS FORECASTS
PSQ: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx 1.5 6.5 xxx
DPS (cps) xxx 2.6 N/A xxx
EPS Growth xxx N/A 100.0% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 15.8 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx 172.4% 0.0% xxx

Dividend yield today if purchased 3 years ago: 1.28%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.54

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 21/09 - ex-div 2.27c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx1.5
DPS All xxxxxxxxxxxxxxx2.6
Sales/Revenue xxxxxxxxxxxxxxx165.3 M
Book Value Per Share xxxxxxxxxxxxxxx38.4
Net Operating Cash Flow xxxxxxxxxxxxxxx40.9 M
Net Profit Margin xxxxxxxxxxxxxxx1.46 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx4.03 %
Return on Invested Capital xxxxxxxxxxxxxxx1.66 %
Return on Assets xxxxxxxxxxxxxxx1.28 %
Return on Equity xxxxxxxxxxxxxxx4.03 %
Return on Total Capital xxxxxxxxxxxxxxx3.61 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx29.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx14 M
Long Term Debt xxxxxxxxxxxxxxx79 M
Total Debt xxxxxxxxxxxxxxx93 M
Goodwill - Gross xxxxxxxxxxxxxxx13 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx19 M
Price To Book Value xxxxxxxxxxxxxxx3.53

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx11.1 M
Capex % of Sales xxxxxxxxxxxxxxx6.70 %
Cost of Goods Sold xxxxxxxxxxxxxxx132 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx27 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

24/11/2023

1

Overweight

$2.10

103.88%

Morgan Stanley notes elevated uncertainty (due to "choppy" trading conditions) as indicated by the absence of FY24 guidance by Pacific Smiles at its AGM.

While there were tougher comparatives and softer customer attendance during September/October, management noted a more favourable appointment outlook into year end, the peak trading period.

Morgan Stanley has a high conviction this profitable-at-scale operator has strategic value materially in excess of the current share price.

Overweight rating and $2.10 target price. Industry view is In-Line.

FORECAST
Morgan Stanley forecasts a full year FY24 EPS of 6.50 cents.
Morgan Stanley forecasts a full year FY25 EPS of 7.80 cents.
Access Stockbroker Research History >

PSQ STOCK CHART

FNArena News on PSQ

1
Australian Broker Call *Extra* Edition – Aug 30, 2023

Aug 30 2023 - Daily Market Reports
2
FNArena Corporate Results Monitor – 25-08-2023

Aug 25 2023 - Australia
3
Australian Broker Call *Extra* Edition – Jul 17, 2023

Jul 17 2023 - Daily Market Reports
4
Australian Broker Call *Extra* Edition – May 02, 2023

May 02 2023 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Mar 06, 2023

Mar 06 2023 - Daily Market Reports

Latest Healthcare services News

1
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
2
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
3
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
4
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps
5
No Straight Covid-Relief For Ramsay Health Care

Nov 15 2022 - Australia
6
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022 - Small Caps
7
Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022 - Small Caps
8
Healius Offers Digital Carrot, Base Remains Soft

May 25 2022 - Australia
9
Ramsay Stakes Future on Mental Health

Dec 20 2021 - Australia
10
Ramsay Health Care: Finally A Break-Out

Nov 09 2021 - Technicals